Running head: PICOT 1 PICOT 6 PICOT STATEMENT AND LITERATURE SEARCH Student’s Name: Idalmis Espinosa Institutional Affiliation: Grand Canyon University Date: 04/23/17 EBS PROCESS The nurses ought to measure the blood pressure of the patients depending on the evidence-based process to ensure accuracy. Accurate measurements are a crucial factor in the effective treatment of diabetes, pediatric and dialysis. The method used to measure the blood pressure in children is different from that employed in adults. In children, the process includes an auscultatory strategy that compares the results with those in the oscillometric tool. PICOT STATEMENT P – Population: Children about 8 to 15 years with a clinical diagnosis of diabetes, pediatric and dialysis. I – Intervention: The subjects will be randomized to have management in different time frames of 2, 4, 6 and eight weeks. C – Comparison: A standardized subject would be used as a control to make active comparisons. This strategy will help us to minimize effects related to not attending the clinic. O – Outcome: Changes in the blood pressure and blood sugar level. T – Time: The outcome would be assessed weekly for eight weeks. Chavers, B. M., Li, S., Collins, A. J., & Herzog, C. A. (2002). Cardiovascular disease in pediatric chronic dialysis patients. Kidney international. According to Chavers and the rest, there is little information regarding the mortality rate of the children with diabetes and renal diseases. The study evaluated the mortality rate in children suffering from pediatric chronic dialysis. Children of ages ranging from 2 to 17 years were identified from the data system of the United States Renal Data system. A sum of 1500 children was eligible for the enclosure. 31 percent of the kids developed cardiac related diseases, while the rest developed other conditions that are related to either diabetes or pediatric dialysis. The study concluded that cardiovascular disease is the primary cause of child mortality and morbidity in pediatric chronic dialysis. Brenner, B. M., Cooper, M. E., & Shahinfar, S. (2001). Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine. Brenner et al. contend that nephropathy is the leading source of renal disease. The researchers evaluated the function of the receptor antagonist in the type 2 diabetes patients and nephropathy. A sum of 1500 patients was randomly selected for assessment over the period of 3 years. The receptor antagonist indicated substantial benefits to the renal in the type 2 diabetes patients and nephropathy. The researchers, therefore, concluded that nephropathy could ca ...

1. Running head: PICOT
1
PICOT
6
PICOT STATEMENT AND LITERATURE SEARCH
Student’s Name: Idalmis Espinosa
Institutional Affiliation: Grand Canyon University
Date: 04/23/17
EBS PROCESS
The nurses ought to measure the blood pressure of the patients
depending on the evidence-based process to ensure accuracy.
Accurate measurements are a crucial factor in the effective
treatment of diabetes, pediatric and dialysis. The method used
to measure the blood pressure in children is different from that
employed in adults. In children, the process includes an
auscultatory strategy that compares the results with those in the
oscillometric tool.
PICOT STATEMENT
P – Population: Children about 8 to 15 years with a clinical
diagnosis of diabetes, pediatric and dialysis.
I – Intervention: The subjects will be randomized to have
management in different time frames of 2, 4, 6 and eight weeks.
C – Comparison: A standardized subject would be used as a
control to make active comparisons. This strategy will help us
to minimize effects related to not attending the clinic.

2. O – Outcome: Changes in the blood pressure and blood sugar
level.
T – Time: The outcome would be assessed weekly for eight
weeks.
Chavers, B. M., Li, S., Collins, A. J., & Herzog, C. A. (2002).
Cardiovascular disease in pediatric chronic dialysis patients.
Kidney international.
According to Chavers and the rest, there is little information
regarding the mortality rate of the children with diabetes and
renal diseases. The study evaluated the mortality rate in
children suffering from pediatric chronic dialysis. Children of
ages ranging from 2 to 17 years were identified from the data
system of the United States Renal Data system. A sum of 1500
children was eligible for the enclosure. 31 percent of the kids
developed cardiac related diseases, while the rest developed
other conditions that are related to either diabetes or pediatric
dialysis. The study concluded that cardiovascular disease is the
primary cause of child mortality and morbidity in pediatric
chronic dialysis.
Brenner, B. M., Cooper, M. E., & Shahinfar, S. (2001). Effects
of losartan on renal and cardiovascular outcomes in patients
with type 2 diabetes and nephropathy. New England Journal of
Medicine.
Brenner et al. contend that nephropathy is the leading source of
renal disease. The researchers evaluated the function of the
receptor antagonist in the type 2 diabetes patients and
nephropathy. A sum of 1500 patients was randomly selected for
assessment over the period of 3 years. The receptor antagonist
indicated substantial benefits to the renal in the type 2 diabetes
patients and nephropathy. The researchers, therefore, concluded
that nephropathy could cause renal diseases that could lead to

3. type two diabetes.
Holloway, M., Mujais, S., Kandert, M., & Warady, B. A.
(2001). Pediatric Peritoneal dialysis training: characteristics
and impact on peritonitis rates. Peritoneal Dialysis
International.
The study was steered to regulate the effects of the training
program on the peritonitis rates pediatric patients. The survey
was done in 170 centers. About 600 children between the ages
of 2 to 15 received the peritoneal dialysis in different centers.
The results of the study indicated that the trained patients had
improved conditions. As such, the researchers concluded that
peritoneal dialysis training is crucial in increasing the rate of
peritonitis in pediatric chronic dialysis patients.
Schröder, C. H., & European Pediatric Peritoneal Dialysis
Working Group. (2003). the management of anemia in pediatric
peritoneal dialysis patients. Pediatric nephrology.
Anemia is regular in constant renal disappointment. Rules for
the finding and treatment of frailty in grown-up patients are
accessible. The study involved the analysis of information from
various journals regarding children suffering from anemia. The
results should indicate that these children are at high risk of
contracting diabetes, and pediatric dialysis. The researchers,
therefore, recommended that the children should be given
proper nutrition that protects them against anemia.
Schaefer, F., Klaus, G., Muller-Wiefel, D. E., & Mehls, O.
(2009). The current practice of peritoneal dialysis in children:
results of a longitudinal survey. Mid-European Pediatric
Peritoneal Dialysis Study Group (MEPPS). Peritoneal dialysis
international,
There has been accruing epidemiological information

4. concerning the exercise of peritoneal dialysis in kids. The
researchers contend that over 200 children have been assessed
since 1993. The treatment of the modalities have been regulated
since 1994, the automated processes of handling the pediatric
dialysis have emerged. Method endurance was 95% at three
years, however, reduced to70% next five years of action, the
principle explanations behind management disappointment
being repetitive peritonitis, ultrafiltration disappointment, or
mutually. All in all, peritoneal dialysis in youngsters, ideally
executed as APD, accomplishes system survival rates like those
detailed for grown-ups. Youthful children are at expanded
hazard for peritonitis. The current observational PD remedy is
of restricted adequacy as far as little solute and liquid
evacuation.
Boehm, M., Vécsei, A., Aufricht, C., Mueller, T., Csaicsich, D.,
& Arbeiter, K. (2005). Risk factors for peritonitis in pediatric
peritoneal dialysis: a single-center study. Pediatric Nephrology
Late US registry information and a European multicenter
concentrate depicted expanded danger of diabetes in young kids
on pediatric dialysis. No primary age-particular hazard
variables could be characterized in these accounts.
Subsequently, the researchers broke down risk components for
the disease in kids regarded by PD as necessary renal
substitution treatment especially looked for age-particular
perspectives. Our review distinguished six risk calculates
univariate investigation, specifically age. Multivariate
examination identified leave site contamination and leftover pee
volume as robust autonomous indicators. In outline, our review
distinguished a few age-ward and age-free hazard components
for the disease.
References
Boehm, M., Vécsei, A., Aufricht, C., Mueller, T., Csaicsich, D.,
& Arbeiter, K. (2005). Risk factors for peritonitis in pediatric
peritoneal dialysis: a single-center study. Pediatric Nephrology,

5. 20(10), 1478-1483.
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F.,
Mitch, W. E., Chavers, B. M., Li, S., Collins, A. J., & Herzog,
C. A. (2002). Cardiovascular disease in pediatric chronic
dialysis patients. Kidney international.
Parving, H. H., ... & Shahinfar, S. (2001). Effects of losartan on
renal and cardiovascular outcomes in patients with type 2
diabetes and nephropathy. New England Journal of Medicine.
Holloway, M., Mujais, S., Kandert, M., & Warady, B. A.
(2001). Pediatric peritoneal dialysis training: characteristics and
impact on peritonitis rates. Peritoneal Dialysis International.
Schaefer, F., Klaus, G., Muller-Wiefel, D. E., & Mehls, O.
(1999). Current practice of peritoneal dialysis in children:
results of a longitudinal survey. Mid European Pediatric
Peritoneal Dialysis Study Group (MEPPS). Peritoneal dialysis
international, 19(Suppl 2), S445-S449.
Schröder, C. H., & European Pediatric Peritoneal Dialysis
Working Group. (2003). The management of anemia in
paediatric peritoneal dialysis patients. Pediatric nephrology.